Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester

Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester Struktur
1950635-34-3
CAS-Nr.
1950635-34-3
Englisch Name:
Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester
Synonyma:
Thalidomide-O-amido-C8-NHBoc;tert-Butyl (8-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)octyl)carbamate;tert-butyl N-[8-(2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamido)octyl]carbamate;Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester
CBNumber:
CB13367394
Summenformel:
C28H38N4O8
Molgewicht:
558.62
MOL-Datei:
1950635-34-3.mol

Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester Eigenschaften

Siedepunkt:
815.0±65.0 °C(Predicted)
Dichte
1?+-.0.06 g/cm3(Predicted)
pka
10.68±0.40(Predicted)

Sicherheit

Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanxi Tihondan Pharmaceutical Technology Co., Ltd
+8618235132063
sales@tihondan.com China 3741 58
SuZhou Medinoah Co.,LTD. 0512-69561983 13914027025
zhang_q@medinoah.com China 4036 58
Jiangsu aikang biomedical research and development co., LTD 025-66110311 13155353615
qzhang@aikonchem.com China 15527 58
Jilin Province Woda Biotechnology Co., Ltd. 13504435624
1927928688@qq.com China 1457 58
Shanghai Kaiwei Chemical Technology Co., Ltd. 021-58461859 15821823057
service@aiviche.com China 49312 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
malulu@leyan.com China 54986 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
czbjpharma@126.com China 18478 58
WEITIXIHAUGONG 0371-53370800 18037197114
2853031799@qq.com China 10008 58
ShenZhen Trendseen Biological Technology Co.,Ltd. 13417589054 13417589054
trendseenbio@gmail.com China 9470 58
Shanghai Easy CDMO Co.,Ltd 021-61734564
August@easycdmo.com China 10030 58

  • Carbamic acid, N-[8-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]octyl]-, 1,1-dimethylethyl ester
  • tert-Butyl (8-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)octyl)carbamate
  • Thalidomide-O-amido-C8-NHBoc
  • tert-butyl N-[8-(2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamido)octyl]carbamate
  • 1950635-34-3
Copyright 2019 © ChemicalBook. All rights reserved